Anastrozole

Active ingredient description

Anastrozole is a potent and highly selective non-steroidal aromatase inhibitor. It inhibits the enzyme aromatase, which is responsible for converting androgens to estrogens. Anastrozole is a drug indicated in the treatment of breast cancer in post-menopausal women.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Anastrozole
L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BG Aromatase inhibitors
Discover more medicines within L02BG03

Medicines

Anastrozole is the active ingredient of these drugs:

Drug
Countries

Italy

Ireland

Spain

Ireland

Germany

Finland

Tunisia

Tunisia

Germany

Australia

Austria

Brazil

Germany

Finland

Singapore

Singapore

Hong Kong

Italy

Brazil

Hong Kong Singapore

Brazil

Cyprus Hong Kong Singapore

Australia

Australia Austria Brazil Canada Cyprus

Singapore

Poland

Tunisia

Lithuania

Poland

Italy

Hong Kong Singapore

Italy

Italy

Italy

Cyprus

Cyprus

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of product characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

2Z07MYW1AZ - ANASTROZOLE

CAS registry number

120511-73-1 - anastrozole

SNOMED-CT

386910003 - Anastrozole (substance)